Dr. Hu, Che-Ming (Jack) ’s Lab胡哲銘 博士 實驗室


Advances in bionanotechnology and cargo-carrying nanocarriers enable existing therapeutics to be reformulated to attain higher potency and safety. Nanotechnology in medicine has shown tremendous value in drug delivery and vaccine preparations, where pharmacokinetics and immune activation can be finely tuned via rational nanomaterials engineering. The research focus of the laboratory is to develop novel therapeutic nanomaterials with an emphasis toward clinical translation. By examining and tackling the interface between materials and biology, we seek to adopt an engineering approach to improve treatments for major diseases including cardiovascular disease, cancer, and infectious disease.


奈米科技於生物醫學上的應用可強化及改善現有的藥物及疫苗製劑,以達到更高的效能和安全性。在藥物輸導及疫苗研發上,奈米粒子都具有極大的影響, 對於藥動學以及免疫激活的調整皆有很大的價值。本實驗室的研究重點以臨床技轉為重心開發創新的醫療材料。通過探討生物材料與生物組織間的作用,來設計與研發新型的奈米製劑以作為疾病的治療,包括心血管疾病,癌症和傳染病等。

Dr. Hu, Che-Ming (Jack)
胡哲銘 博士

Associate Research Fellow

B.S. University of California, Berkeley (Biomedical Engineering) Ph.D. University of California, San Diego (Bioengineering)

Biomaterials and Nanotechnology for Drug and Vaccine Development


Facile Transformation of Murine and Human Primary Dendritic Cells into Robust and Modular Artificial Antigen-Presenting Systems by Intracellular Hydrogelation
Advanced Materials, Jun 07, 2021
Robust induction of TRMs by combinatorial nanoshells confers cross-strain sterilizing immunity against lethal influenza viruses
Methods & Clinical Development, Mar 23, 2021
Nanotechnology advances in pathogen- and host-targeted antiviral delivery: multipronged therapeutic intervention for pandemic control
Drug Delivery and Translational Research, Mar 21, 2021